NCT07444723 2026-03-18
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
National Institutes of Health Clinical Center (CC)
Phase 2/3 Not yet recruiting
Clinical Trials
11 trialsNCT04965454 2025-05-01
ExTRACT-HCC
Queen's Medical Center
Phase 2 Recruiting
NCT05622162 2024-05-22
MIP7
ITEL Telecomunicazioni Srl
Phase 3 Active not recruiting
NCT04391348 2023-11-18
PET-HCC01
Assistance Publique - Hôpitaux de Paris
Phase NA Completed
NCT02397408 2020-11-19
11C- and 18F-Choline PET/MR Imaging for Prostate Cancer
University of California, San Francisco
Phase 2 Completed
NCT04340765 2020-04-13
18F-fluorocholine and 18F-fluoride PET in Prostate Cancer
Buddhist Tzu Chi General Hospital
Phase NA Completed
NCT01395030 2018-09-26
PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection
Queen's Medical Center
Phase 2 Completed
NCT02840552 2018-08-09
The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital
Phase 3 Completed
NCT01993160 2017-01-13
18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
University Health Network, Toronto
Phase NA Completed
NCT01956409 2016-02-04
Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis
National Taiwan University Hospital
Phase 4 Unknown
NCT02074202 2014-02-28
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 3 Unknown